A Phase 2, Randomized, Open-label, Active- and Vehicle-controlled Comparator Study to Assess the Safety, Tolerability, and Efficacy of 2.4% Terbinafine Hydrochloride Topical Solution in Patients with Mild to Moderate Onychomycosis of the Toenails
A Phase 2, Randomized, Open-label, Active- and Vehicle-controlled Comparator Study to Assess the Safety, Tolerability, and Efficacy of 2.4% Terbinafine Hydrochloride Topical Solution in Patients with Mild to Moderate Onychomycosis of the Toenails
Approved By: Bellberry
Clinical Trial Registry Link: